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P u r p o s e : To assess the properties and the osteogenic potency of the calcium phosphate-recom-
binant human morphogenetic protein-2 (CaP-rhBM P-2 composite) on glass-ceramics.
M a t e r ia ls  a n d  M e t h o d s :   Bioactive glass-ceramics,as a scaffold, and a calcium phosphate (CaP) 
solution (pH7.4) were prepared. Recombinant human bone morphogenetic protein-2 (rhBM P-2) was 
purified from CHO -K1 cells by transfecting the cells with BM P-2 cDNA. The glass-ceramics were 
soaked for 3 days at room temperature in saline, a CaP only solution, and a CaP solution containing 
rhBM P-2. Scanning electron microscopy (SEM ), Fourier transform infrared reflection spectroscopy 
(FT-IR ), thin film X-ray diffraction (TF-XRD) and immunofluorescent staining (IF) of the anti-human 
BM P-2 to composite-coated scaffold were performed to verify the characterization of the scaffold 
surface. In addition, RT-PCR of osteogenic marker gene and SEM  photography were performed after 
adhering the mouse preosteoblast M C3T3-E1 cells in order to assess the osteoinductivity.
R e s u lt s :  CaP-rhBM P-2 composite was coated on the surface of glass-ceramics, as confirmed by 
SEM , FT-IR , TF-XRD spectrum, and IF . The CaP-rhBM P-2 composite on the glass-ceramic showed 
a globular shape covered with fine spikes while the CaP on the glass-ceramic showed a fine spike 
structure on the flat glass surface. The expression of collagen type I and alkaline phosphatase 
mRNAs had increased 4 hours after cell seeding. In addition, the level of osteocalcin mRNA ex-
pression had increased significantly by 3 days in the CaP-rhBM P-2 composite compared with the 
control and CaP group. The SEM  photographs showed more active filopodia formation in the 
CaP-rhBM P-2 composite than the other groups. There was extensive newly synthesized extracellular 
matrix around the osteoblasts and CaP-rhBM P-2 composite nodule.
C o n c lu s io n :  The application of CaP-rhBM P-2 composite-surface coating technique on  bioactive 
glass-ceramic is a powerful tool for osteoinduction.
K e y  W o r d s :  Calcium phosphate-rhBM P-2 composite, Surface coating technique, Osteoinductivity




























۩෉ ઴֜ۀ ෇ଲ݁ߧਏ ੰ൞೴ଲൈ(Hydroxyapatite, 
HA), ൈࠤಌਃඑਆൾଲൈ(Tricalcium phosphate, TCP) 
݊଴ॺಌਃծۗէ୨఼, ಻ޭ՛ࢫֻ࣫෍఼, PLA ݊
঍ंැনඔࠤࡉ઩۩෉઴֜ԧசࠜଲ߿ճ଼ۗ1,12).











  ෉ඇ, շକܑনୋ଴ୀ଴շ෴೾෴নۚࢽா-2 








ଲ࣪ճܣճ଼ଞ࡝17,21), INFUSEⓇ Bone Graft (Med-
tronics ॷ)ଭુ઩ছۀrhBMP-2૕֗଀ாਆඓ஺ࠜଲ
૳෉ఴ౟շକ෍২૳೬ൈࠜঃඨฃ෉ુܑ଼ۗ.













  1. CaP-rhBMP-2 복합체 코팅을 위한 glass-cera-
mics 기판
  MgO-CaO-SiO2-P2O5ࠜ 1,450oC઩ছ 2ਏԩ ܛੲ
ڌ଴บ, ਆഓ଴ࠤਆൌ઩ऀઘ2 mm ܪ״ߦԧ੺෇઼
ۗ. ԧ੺෉କࠤࠜं৐෇઱ԧ߿ߦ࠮݃บ, 44μmଭ
తࢱଞߦࢠপं࠱ฃ෇઱, ஹࠑ৤૕ࡿ՚णԧ10：1ଲ


























Fig. 1. Diagram of CaP-rhBMP-2 composite generation and surface coating technique (A) standardized group, (B) control group with




  2. 단백질 침적을 위한 CaP 용액 제조
  142 mM NaCl, 1.50 mM K2HPO4․3H2O, 3.75 mM 
CaCl2ࠜ ࡠ ֹ3ఙஹࠑ৤઩ڌ଴บ, 50 mM TRIS (Sig-
ma-Aldrich CHEMIE Gmbh., Steinheim, Germany)
૕1 M HCl (Sigma-Aldrich CHEMIE Gmbh., Ste-




top filter (Nalgene, NY, USA)ߦࡠֹ෇઱, ׆ൡଡ෌
ಅ්ݡג஺4oC઩ছ٣ୋ࣪ւ෇઼ۗ.
  3. CaP-rhBMP-2 복합체의 기판 표면 코팅
  ׆ൡଭୣԹ࡟ୡ1 cm2 (ڔଲ1 mm)ۥ30 mlଭ଴ॺ
ಌਃ૳ઁ઩෌ಅܣܑߧծฏ෇઼ۗ. ඝஜ֞ଠ׆ൡଡ঍
ࠤਐસ৤઩, ۩୺֞ଠCaP ૳ઁ઩෌ಅ෇ճ, ਓ෠֞ଠ




  4. CaP-rhBMP-2 복합체의 기판 표면 코팅에 대한 
SEM, FT-IR 및 TF-XRD 촬영
  5×4 mm (ڔଲ1 mm)ଭ׆ൡଡԨ֞࣢ߦ5 mlଭ
঍ࠤਐસ৤, CaP ૳ઁ, 10μg/mlଭrhBMP-2ԧషԧ
ܤCaP ૳ઁ઩෌ಅ෇઱, 25oCଭා૊୺Ս઩ছ3ଵԩ
ࢱଦਏ೮บ, Scanning Electron Microscopy (SEM), 
Fourier transform infrared reflection spectrometry 
(FT-IR) ࢫthin-film X-ray diffraction (TF-XRD)
ࠜധැ׆ൡඝ࡟෴೾࣡ฃ૕ࢄா࣡ฃࠜՑॷ෇઼ۗ. 
  5. rhBMP-2에 대한 면역형광 염색
  5×4 mm (ڔଲ1 mm)ଭ׆ൡଡ5 mlଭCaP ૳ઁ, 
1μg/mlଭ rhBMP-2૕ 10μg/mlଭ rhBMP-2ԧԨԨ
షԧܤCaP ૳ઁ઩෌ಅ෇઱, 25oCଭා૊୺Ս઩ছ3ଵ
ԩࢱଦਏಯCaP-rhBMP-2 ࣫෍఼ࠜ׆ൡඝ࡟ಅୡਏ
ವۗ. ࢱଦ3ଵ௒઩׆ൡଡPhosphate buffered saline 
(PBS, Invitrogen Corp., NY, USA)ߦܪఙߢপఴ෉
บ, 3% formaldehyde ૳ઁ઩ۡԧ4oC઩ছ20ंԩճ
୨෇઼ۗ. PBSߦ5ंԩܪఙߢপఴ෉ܶ, ଴ԩBMP-2
઩۩෉ଵఙා఼(goat polygonal anti-human BMP- 
2 antibody, Santa Cruz Biotech. Inc., CA, USA)ࠜ
1% ૴෯఻ੵऀࢢ(bovine serum albumin, BSA, Sig-
ma-Aldrich CHEMIE Gmbh., Steinheim, Germany)
઩1：200ଭणଘߦ็জ෉૳ઁଡ׆ൡ઩ୡ૳෇઱ঃ
૊઩ছ2ਏԩܛੲࢱଦ෇ճ, ۗਏPBSߦ5ंԩপఙߢ
পఴ෇઼ۗ. 2ఙා఼଴෴ֈanti-goat IgG (Vector 
Lab. Inc., CA, USA)ࠜ1% BSA઩1：300ଞߦ็জ෇
઱׆ൡ઩ୡ૳෉บ, ঃ૊, ੹୺Ս઩ছ45ंԩࢱଦ෇
઱PBSߦপఙߢপఴ෇઼ۗ. পఴଲفٍ׆ൡ઩෴ֈ
෮ࢠլ૳mounting media (Vector Lab. Inc., CA, 
USA)ࠜୡ૳෉บ, cover glassߦ܀ઘ෴ֈ෮ࢠլ෇઩
ছւఝ෇઼ۗ.
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Table 1. PCR Primer and Condition for Osteogenic Marker Genes
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
Group Primer name 5'-＞3' Product size (bp) Rxn temp. (cycle)
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
1 Mouse 18S r RNA Forward ggt aca gtg aaa ctg cga at 168 50 (28)
Reverse ggg ttg gtt ttg atc tga ta
2 Mouse type (I) collagen Forward cct ggt aaa gat ggt gcc 222 58 (28)
Reverse cac cag gtt cac ctt tcg cac c
3 Mouse osteocalcin Forward cct cag tcc cca gcc cag atc c 219 58 (28)
Reverse cag ggc aga gag aga gga cag g
4 Mouse ALP Forward gcc ctc tcc aag aca tat a 372 55 (35)
Reverse cca tga tca cgt cga tat cc
󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏󰠏
  6. 마우스 조골아세포인 MC3T3-E1 세포의 기판 흡착 
후, 조골세포 표식 유전자의 발현
  5×4 mm (ڔଲ1 mm)ଭ׆ൡଡ5 mlଭ঍ࠤਐસ৤, 
CaP ૳ઁ, 10μg/mlଭrhBMP-2ԧషԧܤCaP ૳ઁ઩
෌ಅ෇઱, 25oCଭා૊୺Ս઩ছ3ଵԩࢱଦਏ೮บ, ࠬ
૴ਆ୺շੰপඑ଴MC3T3-E1 পඑࠜ2×104 পඑଭ
णଘߦใచ෇઱37oC, 5% CO2 ࢼઑ׆઩ছ౟ԧࢼઑ෇
઼ۗ. 4ਏԩ, 12ਏԩ, 24ਏԩֻࠤճ72ਏԩԩգଞߦ
RNeasy mini kit (Invitrogen Corp., NY, USA)ࠜଲ૳
෇઱RNAࠜ౟ౢ෇ճ, ౟ౢ෉RNA 1μg઩0.2μg/ ml
ଭOligo d(T)15-17 primerࠜషԧ෇઱70oC઩ছ5ंԩ
ऀచࢱଦ෉บ, ઝଣ઩ছ5ंԩਐෳۗ. AccupowerⓇ 




phire PCR premix (Superbio, Korea) tube઩્բۡ





  7. 마우스 조골아세포인 MC3T3-E1 세포의 기판 흡착 
후, SEM을 이용한 세포 형태 분석
  5×4 mm (ڔଲ1 mm)ଭ׆ൡଡ5 mlଭ঍ࠤਐસ৤, 
CaP ૳ઁ, 10μg/mlଭrhBMP-2ԧషԧܤCaP ૳ઁ઩
෌ಅ෇઱, 25oCଭා૊୺Ս઩ছ3ଵԩࢱଦਏ೮บ, ࠬ
૴ਆ୺շੰপඑ଴MC3T3-E1 পඑࠜ2×104 পඑଭ
णଘߦใచ෇઼ۗ. 37oC, 5% CO2 ࢼઑ׆઩ছ3ଵԩ౟
ԧࢼઑ෉ܶ, PBSߦܪఙߢপఴ෇઼ۗ. পఴ෉পඑԧ
ใచܤ׆ൡଡ4% paraformaldehyde (w/v, Sigma- 
Aldrich CHEMIE Gmbh., Steinheim, Germany)ଞߦ
2ଵԩճ୨෉ܶ, ઩೶ોଭړܑࠜ10-95%ג஺০ఙୡ
ଞߦళࠤ෇઱೷৤ࢱଦଡ෇઼ۗ. ஼վՍ୺׆઩׆ൡଡ
ٶճ૗ୢํ࠱ࠦۗଣDESK II gold sputter coater 
(Denton)ଡଲ૳෇઱gold ಸ൝ଡਏෘ෇઼ۗ. ಸ൝෉
׆ൡଡHitachi 3500 scanning electron microscope 
(Hitachi, Tokyo, Japan)ଡଲ૳෇઱ւఝ෇઼ۗ.
결  과
  1. CaP-rhBMP-2 복합체의 코팅에 따른 glass-ce-
ramic 기판 표면의 변화
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Fig. 2. Scanning electronic microscopic finding of glass ceramic only, glass ceramic with CaP coating, and glass ceramic with CaP
and rhBMP-2 coating.




























Fig. 3. TF-XRD and FT-IRRS analysis after glass ceramic coating.
  2. CaP-rhBMP-2 복합체-glass-ceramic에 대한 인
간 BMP-2의 면역 형광염색
  ׆ൡଡ঍ࠤਐસ৤૕CaP ૳ઁ઩෌ಅ෉ඝஜ֞ր۩
୺֞઩ছۀBMP-2઩۩෉෴ֈා఼ࢱଦଲւఝܣ஺ੴ
੼ଞ࡝, 1μg/mlր 10μg/mlଭ rhBMPԧඑ෌ܤ CaP 
૳ઁ઩෌ಅ෉ਓ෠֞઩ছۀۚࢽாړܑଭ୼ୡଞߦ෴




  3. CaP-rhBMP-2 복합체-glass-ceramic에 흡착된 
MC3T3-E1 세포의 조골세포 표식 유전자 발현
  ࠬ૴ਆ୺շੰপඑ଴MC3T3-E1পඑࠜԨ֞ଭ׆ൡ
઩ใచ෉஺4ਏԩ௒઩ඝஜ֞, ۩୺֞րण֗෇઱ਓ෠
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+CaP +CaP+1 ug/ml rhBMP2 +CaP+10 ug/ml rhBMP2
Fig. 4. Immuno-fluorescent stain


































Fig. 5. mRNA expression of osteogenic marker gene mRNA 
(collagen type I, osteocalcin, alkaline phosphatase) in mouse 













  4. CaP-rhBMP-2 복합체-glass-ceramic에 흡착된 
MC3T3-E1 세포의 세포 흡착능 및 분화 형태 분석





ଡւఝ්৤଼તۗ(Fig. 6). ށ෉CaP-rhBMP-2 ࣫
෍఼-glass-ceramic઩ ใచܤMC3T3-E1পඑଭ լ





















(Octacalcium phosphate, OCP)઩rhBMP-2 ۚࢽாଡ
ಸ൝෇઱ܪԹշէৃࢽছࡦ܄઩ছ਑঍շ୺஻঍নଡ
କܑ෉ࢭ଼ۗ. ށ෉ఴ౟շଜ෍২઩۩ැֽౖ઩ঃඨ
ฃܤINFUSEⓇ Bone Graft (Medtronics)ଭլ૴, ಻ޭ
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Fig. 6. Scanning electronic microscopic finding of mouse osteoblasts (MC3T3-E1) on glass ceramic only, glass ceramic with CaP coating,




























ඝஜ֞, CaP࠮ଡ ಸ൝෉ ۩୺֞ր ण֗෇઱, CaP- 
rhBMP-2 ࣫෍఼ԧಸ൝ܤ׆ൡଲ࠻૴૴৤෉୺շপ
එंฃࠜକܑ෌ଡւఝ්৤଼તۗ. ށ෉۳૵ڎޭ૶
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= 국문초록 =
목 적: Glass-ceramics 표면에 코팅된 인산칼슘-재조합 인간 BMP-2 (CaP-rhBMP-2) 복합체의 특성과 조골 
세포 분화능 검증을 위함이다.
대상 및 방법: 기판으로는 바이오활성 glass-ceramics를, 기판 함침을 위한 인산칼슘용액(CaP, pH7.4)을 준비
하였다. 재조합 인간 골 형태형성 단백질-2 (rhBMP-2)은 BMP-2 cDNA가 전이된 CHO-K1 세포로부터 분리 
정제하였다. Glass-ceramics은 생리식염수, CaP 단독 용액, rhBMP-2가 포함된 CaP 용액에 3일 동안 상온에서 
함침하였다. 복합체가 코팅된 기판 표면의 특성을 확인하고자, 주사 전자현미경, 적외선 반사 분광학, 박막 X-선 
회절과 항-인간 BMP-2에 대한 면역 형광 염색을 시행하였다. 또한, 조골세포 분화능을 평가하고자, 마우스 
조골아세포인 MC3T3-E1 세포를 흡착시킨 후, 조골세포 표식 유전자에 대한 RT-PCR과 SEM을 시행하였다.
결 과: CaP-rhBMP-2 복합체가 glass-ceramics 표면에 코팅되어 있음을 SEM, FT-IR 및 TF-XRD, IF 결과를 
통해 확인할 수 있었다. Glass-ceramics 위의 CaP-rhBMP-2 복합체는 미세한 침상 구조로 덮인 구형을 나타낸 
반면, CaP 군에서는 glass-ceramics 표면에 미세한 침상 구조가 평평하게 퍼져있었다. 제1형 교원질과 알칼리 
인산화 효소 mRNA의 발현은 세포 흡착 후 4시간째에, 또한 osteocalcin mRNA의 발현은 3일째에 CaP- 
rhBMP-2 복합체군에서 표준군, CaP군과 비교하여 뚜렷하게 증가되어 있었다. SEM 촬영 결과, 실험군에 흡착된 
MC3T3-E1세포에서 다른 군과 비교하여 활성화된 filopodia 형성이 관찰되었다. 조골세포와 CaP-rhBMP-2 복합
체 주변에는 신생 세포기질의 합성도 관찰되었다.
결 론: 바이오 활성 glass-ceramic에서의 CaP-rhBMP-2 복합체-표면 코팅 기술의 적용은 조골 분화 유도에 
있어서 매우 강력한 기법이다.
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